Found 0 matching trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
PHASE3A randomized study evaluating the safety and efficacy of elagolix in the ma...
Location
Multiple Locations
Hormonal Effects of the Oral Gonadotropin Releasing Hormone (GnRH) Antagonist at Different Periods of the Menstrual Cycle
PHASE4The purpose of this study is twofold: First, to see if elagolix can suppres...
Location
Multiple Locations
Global Study to Evaluate the Long-Term Safety and Efficacy of Elagolix in Women With Moderate to Severe Endometriosis-associated Pain
PHASE3A randomized study evaluating the continued safety and efficacy of elagolix...
Location
Multiple Locations
An Oral GnRH Antagonist to Treat Mild Autonomous Cortisol Excess (MACE) Due to Adrenal Adenomas in Postmenopausal Women
PHASE4The purpose of this research study is to determine if treatment with Elagol...
Location
Icahn School of Medicine at Mount Sinai
Pre-IVF Treatment With a GnRH Antagonist in Women With Endometriosis
PHASE3A Phase 3 clinical trial of oral GnRH antagonist pre-treatment for women wi...
Location
University of Colorado Department of Obstetrics & Gynecology
Comparison Elagolix vs Depot Leuprolide Prior to Frozen Embryo Transfers in Patients With Endometriosis
EARLY_PHASE1Patients who have been previously surgically diagnosed with endometriosis a...
Location
Colorado Center for Reproductive Medicine